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Abstract
Background: Many sedative agents, including anesthetics, produce explicit memory impairment by largely
unknown mechanisms. Sharp-wave ripple (SPW-R) complexes are network activity thought to represent
the neuronal substrate for information transfer from the hippocampal to neocortical circuits, contributing
to the explicit memory consolidation. In this study we examined and compared the actions of two
barbiturates with distinct amnesic actions, the general anesthetic thiopental and the anticonvulsant
phenobarbital, on in vitro SPW-R activity.
Results: Using an in vitro model of SPW-R activity we found that thiopental (50–200 µM) significantly and
concentration-dependently reduced the incidence of SPW-R events (it increased the inter-event period
by 70–430 %). At the concentration of 25 µM, which clinically produces mild sedation and explicit memory
impairment, thiopental significantly reduced the quantity of ripple oscillation (it reduced the number of
ripples and the duration of ripple episodes by 20 ± 5%, n = 12, P < 0.01), and suppressed the rhythmicity
of SPWs by 43 ± 15% (n = 6, P < 0.05). The drug disrupted the synchrony of SPWs within the CA1 region
at 50 µM (by 19 ± 12%; n = 5, P  < 0.05). Similar effects of thiopental were observed at higher
concentrations. Thiopental did not affect the frequency of ripple oscillation at any of the concentrations
tested (10–200 µM). Furthermore, the drug significantly prolonged single SPWs at concentrations ≥50 µM
(it increased the half-width and the duration of SPWs by 35–90 %). Thiopental did not affect evoked
excitatory synaptic potentials and its results on SPW-R complexes were also observed under blockade of
NMDA receptors. Phenobarbital significantly accelerated SPWs at 50 and 100 µM whereas it reduced their
rate at 200 and 400 µM. Furthermore, it significantly prolonged SPWs, reduced their synchrony and
reduced the quantity of ripples only at the clinically very high concentration of 400 µM, reported to affect
memory.
Conclusion: We hypothesize that thiopental, by interfering with SPW-R activity, through enhancement
of the GABAA receptor-mediated transmission, affects memory processes which involve hippocampal
circuit activation. The quantity but not the frequency of ripple oscillation was affected by the drug.
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Background
Sedative drugs, including barbiturates, induce episodic
memory impairment in humans [1-4] through poorly
understood mechanisms. The hippocampus appears to be
a key structure in episodic memory processing [5-7].
Timely structured activity of cell assemblies is thought to
underlie encoding and transient storage of explicit mem-
ory traces in the hippocampal circuit [8]. These memory
traces are reactivated during subsequent behavioral stages
[9-11] namely during bursts of activity called sharp wave-
ripple complexes (SPW-R) consisting of a relatively slow
wave (sharp wave; [12-14] crowned by high frequency
oscillation (ripple, 100–200 Hz; [13,15-17]. SPW-R activ-
ity occurs mainly during slow wave sleep and awake
immobility [13,18], and it is also observed in high tempo-
ral proximity to the experienced event [19]. Studies show-
ing temporal correlation between SPW-R and neocortical
activity [17,20,21] suggest that SPW-R constitute the neu-
ronal substrate for information transfer in the hippoc-
ampo-neocortical circuits [22], contributing to the long-
term storage of short-term memories and thus to memory
consolidation in neocortical circuits [17,23,24]. The study
of the effects of amnesia-inducing agents on hippocampal
SPW-R activity becomes increasingly interesting in light of
the above research evidence.
In vitro experimentation continuously provides new data
demonstrating the great impact of isolated preparations as
models in elucidating the mechanisms underlying brain
rhythms and the action of centrally acting drugs on these
rhythms [25,26]. In particular, slice preparation offers
unique advantages of experimental control for studying
the network mechanisms underlying distinct and isolated
elements of cooperative population activities. In vitro
models of SPW-R activity have recently been developed
using hippocampal preparations [27-31]. In vitro SPW-R
activity presents certain experimental advantages includ-
ing its spontaneous generation in hippocampal slices
under standard conditions without being induced by
pharmacological agents or other experimental manipula-
tion. Thus, it is especially suitable for pharmacological
examinations since complex drug interactions which
could interfere with the mechanisms underlying the
effects of the drug under investigation are avoided.
Using the in vitro SPW-R we studied the effects of two bar-
biturates, thiopental and phenobarbital, which have dif-
ferent clinical usage and display distinct effects on
memory processes. Thiopental, one of the most com-
monly used barbiturates, is an intravenously used general
anesthetic, producing anterograde amnesia [32-34]. It
preferentially affects explicit memory [1,35]. General
anesthetics apparently affect the transition from short-
term to long-term storage of explicit memories [36]. On
the other hand, the anticonvulsant phenobarbital shows
less consistent effects on memory processes. Some studies
revealed no detectable effects on memory [37,38] while
others describe memory impairment [39,40] especially
when doses at the high end of the therapeutic range were
used [41,42].
We show that at clinically relevant concentrations the two
drugs differently affect SPW-R complexes, with thiopental
strongly affecting activity and phenobarbital displaying
no significant effects.
Results
Characteristics of SPW-R activity
Spontaneous sharp wave-ripple (SPW-R) complexes (Fig.
1A,B) were consistently recorded in seventy-eight ventral
hippocampal slices taken from forty-eight animals. SPWs
in st. pyramidale consisted of positive potentials with a
mean amplitude, half-width and duration of 0.22 ± 0.02
mV (n = 74), 24.8 ± 6.5 ms (n = 60) and 79.8 ± 5.4 ms (n
= 60) respectively, and they occurred every 0.410 ± 0.02
sec (n = 74) (Fig. 1B–C,E). SPWs although not literally
oscillatory, presented a certain degree of rhythmicity evi-
dent using auto-correlation analysis [31], (Fig. 1F). Rip-
ples appeared as a high-frequency oscillation associated to
the SPW slow potential and they were detected after band-
pass filtering raw signal at 100–300 Hz (Fig. 1C). Ripple
oscillation was also revealed as a clearly distinguishable
peak in fast Fourier transforms (Fig. 1D). The mean values
of the ripple number inside a ripple episode, the duration
of ripple episode and the frequency of ripple oscillation
were respectively 7.0 ± 0.3 ripples (n = 49), 38 ± 2 ms (n
= 49) and 161.0 ± 2.5 Hz (n = 69). Multiunit activity,
revealed after band-pass filtering, was associated with
SPW-R events (Fig. 1C-4). Similarly to previous observa-
tions [43] the mean frequency of multiunit activity
accompanying SPW-Rs ranged among slices from 75 to
420 Hz (mean value 232 ± 36 Hz, n = 9 slices). Most of
the experiments were carried out in CA1; however, in
some experiments recordings were made in CA3. Statisti-
cal comparisons (independent t-test) showed that the dif-
ferent measures did not significantly differ between the
two fields. For instance, in CA1 the mean values of ampli-
tude, half-width and duration of SPWs were respectively
0.21 ± 0.02 mV (n = 63), 25.0 ± 1.0 ms (n = 46) and 79.0
± 6.3 ms (n = 46); the corresponding values in CA3 (n =
11) were respectively 0.27 ± 0.05 mV, 24 ± 1.2 ms and
83.0 ± 9.9 ms. The measures of ripples were similar
between CA1 and CA3 as well, although the ripple epi-
sodes were slightly longer in CA1 than in CA3, but not sig-
nificantly so. The mean values of the ripples' number, the
duration of the ripple episode and the ripple frequency in
CA1 (n = 31) vs CA3 (n = 8) were respectively 7.4 ± 0.4 vs
6.7 ± 0.6 ripples, 41.2 ± 2.7 vs 36.3 ms and 161.0 ± 3.3 vs
164.0 ± 6.5 Hz.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
Page 3 of 16
(page number not for citation purposes)
The pharmacological experiments in the present study
were carried out at 32°C, which is 4–7°C lower than the
body temperature in the intact animal [44]. In order to
examine the effects of temperature on SPWs and ripple
oscillation, the temperature in the recording chamber was
changed systematically while continuously recording
SPW-R activity from the CA1 pyramidal layer. The temper-
ature changes significantly affected the rate of SPWs and
the ripple frequency, but not the magnitude (i.e. ampli-
tude or power) of the events. Furthermore, SPWs and rip-
ples were affected differently. In particular, lowering the
temperature from 32 to 27°C significantly slowed down
SPWs by 49 ± 6 % (paired t-test, n = 4, P < 0.01) (Fig. 2).
The mean rate of SPWs was not significantly changed
when the temperature was increased from 32°C to 37°C,
as has been also previously observed [45]. However, at
37°C SPWs were often generated as bursts of two to four
waves (Fig. 2B). The ripple frequency changed linearly
with temperature, increasing monotonically when the
temperature was increased from 27 to 37°C. In particular,
the ripple frequency increased by 29.4 ± 0.7 % from 27 to
32°C and by 38 ± 4 % from 32 to 37°C (Fig. 2B,C). The
mean value of the ripple frequency observed at 32°C (160
± 8 Hz) was at the range of the ripple frequency observed
in vivo (i.e. 120–200 Hz) [15,46-48]. However, at 27°C
and 37°C the values of ripple frequency (113 ± 6.6 Hz
and 221 ± 12.5 Hz respectively) were at the limits of the
physiological range of the ripple frequency. These experi-
ments indicated that, although certain properties of SPW-
Rs in vitro are affected by temperature, in vitro SPW-R
activity closely resembles its in vivo counterpart when
slices are maintained at the temperature of 32°C.
Thiopental effects on in vitro SPW-R complexes
Thiopental was applied in the perfusion medium at the
concentrations of 10, 25, 50, 100 and 200 µM. Clinical
concentrations of thiopental range from 10 to about 100
µM [1,32,35,49-51]. Somewhat larger maximal concen-
trations have been reported in studies using experimental
animals [52-55]. Recordings were typically performed in
CA1, but in some experiments (no more than three at
each concentration) recordings were made in CA3. Since
no difference was found between CA1 and CA3 the meas-
ures obtained from the two fields were pooled together.
Thiopental produced concentration-dependent and
reversible changes in most of the characteristics of SPWs
and ripples. As illustrated in Fig. 3, thiopental at concen-
trations ≥50 µM significantly reduced the rate of SPWs
(i.e. it increased the period between single SPWs) and pro-
longed single SPW (Fig. 2A &2C), without significantly
affecting the amplitude of potentials, the mean percent
change of which at the five concentrations (10, 25, 50 100
and 200 µM) was respectively 1.6 ± 5.8% (n = 12), 0.4 ±
4.3% (n = 18), 16.4 ± 8.5% (n = 21), 13.3 ± 12.2% (n =
12) and 10.3 ± 18.7% (n = 9). Furthermore, the drug sig-
In vitro SPW-R activity recorded in the st. pyramidale of  CA1 region of ventral hippocampal slices perfused with  standard medium Figure 1
In vitro SPW-R activity recorded in the st. pyrami-
dale of CA1 region of ventral hippocampal slices per-
fused with standard medium. A. Continuous long-lasting 
field recording of SPWs (trace on the top, low-pass filtered 
at 35 Hz) and the corresponding time histograms of ampli-
tude (middle) and period (bottom). Data were obtained from 
a slice four hours after its placement on the recording cham-
ber. Note the persistency and stability over time of both 
characteristics of SPWs. B. Record of spontaneous activity 
obtained from a different slice, presented at a faster sweep 
speed. C. A wide band record of a single SPW-R event (C1) 
and the filtered sweeps are shown, illustrating the distinct 
components of the event. Low-pass (0.5–30 Hz) and band-
pass (100–300 Hz) filtering reveals the slow wave (C2) and 
the associated ripple oscillation (C3) respectively. Band-pass 
filtering at very high frequencies (0.5–1 kHz, C4) discloses 
the burst-like multiunit activity occurring mostly during the 
rising and peaking phases of the slow positive potential. D. 
FFT from 1 min raw record of spontaneous activity showing 
the difference in power between SPWs (upper diagram) and 
ripples (lower diagram, same power spectrum shown at a 
greater magnification). SPW dominant peak is at 5–10 Hz. 
Ripple activity is at ~150 Hz. E. Histogram of period (inter-
event interval) of SPWs calculated from a population of 
slices, showing that most of the slices displayed a period 
between 0.2–0.6 sec, which correspond to a frequency range 
of 1.5–5.0 Hz. F. Auto-correlogram from a 5 min low-pass 
record from a distinct experiment, showing the typical 
degree of rhythmicity of SPWs.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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nificantly reduced rhythmicity of SPWs (starting at 25 µM;
Fig. 3B) and the synchronization of SPWs across the CA1
region, as observed by the reduction in cross-correlation
(Fig. 3D). At the concentrations of 100 and 200 µM the
drug abolished spontaneous activity in 4/15 and 5/12
slices respectively.
Thiopental at a concentration-dependent manner short-
ened ripple episodes by reducing the number of ripples in
each episode, without changing the ripple frequency (Fig.
4). Taking into account that thiopental prolonged single
SPW it resulted that less of the SPW waveform was accom-
panied by a ripple episode following drug application.
Thiopental significantly reduced the amplitude and the
power of ripple oscillation. The ripple number and the
duration of ripple episode were proven the most sensitive
measures, with the drug significantly affecting these at the
concentration onset of 25 µM (paired t-test, P < 0.01) and
Effects of temperature on SPWs and ripple oscillation Figure 2
Effects of temperature on SPWs and ripple oscillation. A. Representative experiment showing the time course of the 
temperature changes (a) and the induced fluctuations in the period of SPWs recorded from the CA1 pyramidal layer (b). The 
dotted line in "a" marks the temperature of 32°C. In "b", the three representative temperatures (32°C, 27°C and 37°C) are 
indicated for purpose of comparison. During the increase of the temperature from 34–35°C to higher values, the histogram of 
the period bifurcated. This deviation of the values was due to the fact that SPWs were frequently generated in a burst-like fash-
ion (shown in B), where consecutive waves appeared at short intervals, whereas at the same time the period between bursts of 
events increased. B. Continuous recording of SPW-R complexes (left column) and power spectra at the high frequency range 
(right column) obtained at different temperatures. Single ripple episodes (band-pass filtered traces) are shown as inserts in 
spectral plots; calibration bars: 10 µV, 10 ms. At 37°C SPWs appeared frequently as bursts of several events. Ripple frequency 
changed monotonically with temperature. Note that at 37°C ripple frequency exceeded 200 Hz. Data in "A" an "B" were col-
lected from two different slices. C. Collective date of the period of SPWs and of the frequency of ripple oscillation at three dif-
ferent temperatures. Asterisks indicate significant differences with reference to the group of 32°C (paired t-test, at P < 0.05, n 
= 4).BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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Effects of thiopental on Sharp Waves Figure 3
Effects of thiopental on Sharp Waves. A. Example of field recordings (a) and plot of instantaneous period (b) illustrating 
that thiopental induced a concentration-dependent and reversible increase in the inter-event period. Horizontal bars in "b" 
denote the time of application of consecutively larger drug concentrations. Relatively large data values of period during 100 and 
200 µM of the drug are curtailed for reasons of clarity of lower values. Note the great value dispersion of instant period during 
drug application at ≥50 µM. Data in "a" and "b" were obtained from two different slices. The collective data plot (percent 
changes) of period is shown in (c). The asterisk here, as in the subsequent collective plots in the figure, denotes the lowest 
concentration with statistically significant drug action (paired t-test, P < 0.001 at 50 µM and P < 0.05 at 100–200 µM). The 
number of slices studied at the five concentrations, of 10, 25, 50, 100 and 200 µM, were respectively 12, 18, 22, 12 and 8. Error 
bars not shown were smaller than the size of the symbol. B. Example of auto-correlation before and during 50 µM thiopental 
(a) and collective auto-correlation plot (b) showing the disruption of rhythmicity at concentrations ≥25 µM (paired t-test, P < 
0.05 at 25 µM and P < 0.01 at ≥50 µM). Numbers of slices studied at the five concentrations were 5, 6, 12, 8 and 4. C. Example 
of thiopental-induced prolongation of SPWs (a) at two different concentrations. Averages of low-pass filtered sweeps taken 
from a two minute epoch are shown. Dotted traces are control sweeps. The corresponding collective plot (b) shows that sig-
nificant prolongation of single SPWs occurred at drug concentrations ≥50 µM (paired t-test, P < 0.01). D. Effect of thiopental 
on SPWs' synchronization along the CA1 region. Single SPWs simultaneously recorded from two locations along the CA1 st. 
pyramidale, measuring 1 mm, are shown in "a", before (traces on the left) and during application of 50 µM thiopental (traces on 
the right). Sweeps were low-pass filtered in order to make feasible the time-discrimination of their peaks. Note the increased 
phase-lag (marked by dotted lines) during drug application (9.25 ms) compared with control condition (3.8 ms). The cross-cor-
relation plot from another slice (b) illustrates the large decrease of function value during drug application at 100 µM. The col-
lective plot (c) shows that significant suppression of synchrony started at 25 µM and reached a plateau at 100 µM (P < 0.05 at 
50 µM and P < 0.01 at ≥50 µM). Numbers of slices studied at the five concentrations were 3, 5, 5, 4 and 4.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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reaching maximal effect values at the concentration of 50
µM (P < 0.001; Fig. 4C). The power of ripple oscillation
was significantly reduced at concentrations ≥50 µM (P ≤
0.01), whereas the amplitude was significantly affected at
concentrations of 100 and 200 µM (P < 0.05; Fig. 4C).
Even at high concentrations thiopental only induced a
small, statistically non significant reduction in the fre-
quency of the oscillation (maximal reduction by 17 ± 2.6
% at 100 µM). It is interesting that at the lowest concen-
tration used (10 µM), the drug produced a consistent, yet
statistically insignificant increase in the power of ripple
oscillation (by 14.87 ± 11.6 %; Fig. 4B-b,C), and a small
acceleration of the rate of SPWs (reduction in period by
11.1 ± 4.5 %; Fig. 3C), reminiscent of the EEG-activation
at very light levels of general anesthesia [54].
It has been shown that thiopental reduces neuronal excit-
ability [56]. In order to examine the action of the thiopen-
tal on the neuronal excitability, we measured SPW-R-
associated multiunit activity before and during applica-
tion of the drug [57]. The calculation of rate was made
using the same time window at control and drug condi-
tions. The duration of the window equated to the time
around the maximum rate value, which included the 75%
of the multiunit rate histogram. Thus, differences in the
rate could be attributed to actual changes in the rate rather
than to the total number of units fired during an SPW-R
episode, taken into account that the drug induced short-
ening of SPW-R episodes. Thiopental produced significant
and reversible reduction in the mean rate of multiunit
activity by 43.8 ± 6.5 % (n = 9; P < 0.05) (Fig. 4D).
Previous studies have shown that thiopental reduces exci-
tatory synaptic events but only at concentrations greater
than 50 µM [58-60]. We examined the effect of thiopental
(50 and 100 µM) on the evoked field excitatory postsyn-
aptic potential (fEPSP) recorded from the CA1 st. radia-
tum. Experiments were performed using the half-maximal
fEPSP found on the base of input/output curve. In line
with previous observations [58,60] we found that thio-
pental did not affect fEPSPs at 50 µM (Fig. 5). However, in
contrast to previous studies [58,59,61] we did not observe
any significant effect of thiopental at 100 µM.
Generation of SPW-Rs does not require activation of
NMDA receptors [31,45,62-64]. However, conditions
facilitating NMDA receptor activation, such as low magne-
sium medium, or direct exogenous activation of NMDA
receptors, may affect SPW-R activity [64]. On the other
hand, thiopental (50 µM) elicits burst suppression activity
in the neocortex by a mechanism involving activation of
NMDA receptors [58,65]. From a phenomenological
point of view, there was a similarity between spontaneous
activity observed in the present study under high drug
concentrations and burst suppression activity (i.e. both
are low-frequency high-voltage activity separated by peri-
ods of silence). Using recordings of SPW-R activity from
the CA1 field, we examined whether NMDA receptors par-
ticipate in the effects produced by thiopental at the con-
centrations of 50 or 100 µM. As shown in figure 6, in the
presence of NMDA receptor antagonist CPP (10 µM), thi-
opental produced similar effects to those observed when
the drug was administered alone, in standard medium. In
particular, thiopental, at both concentrations (i.e. 50 and
100 µM) significantly increased the period of SPWs and
prolonged single SPWs without affecting the amplitude of
the waves and significantly reduced their rhythmicity (P <
0.05; n = 9 and n = 8 at 50 and 100 µM respectively) (Fig.
6A–C). Furthermore, the drug significantly reduced the
quantity of ripples (i.e. their number, duration and
power, P < 0.05; n = 7 and n = 5 at 50 and 100 µM respec-
tively) without affecting the ripple frequency (Fig. 6D;
examples shown in inserts of Fig. 6A &6B). At 100 µM, thi-
opental abolished SPW-R activity in two out of ten slices.
Phenobarbital effects on in vitro SPW-R complexes
Phenobarbital was applied at the concentrations of 25,
50, 100, 200 and 400 µM and its effects on SPW-R activity
were studied with recordings made from the CA1 field.
Clinically relevant serum concentrations of phenobarbital
range from 40 to 160 µM [66-68]. Free serum concentra-
tions exceeding 100 µM produce severe sedation [69].
Given that cerebrospinal fluid concentration of phenobar-
bital is about half of the free serum levels [70], the maxi-
mum values of therapeutic (anticonvulsant)
cerebrospinal fluid concentrations does not usually
exceed 100 µM. As shown in the figures 7 and 8, pheno-
barbital at the concentration of 25 µM had no significant
effect on SPW-R activity. At the concentrations of 50 and
100 µM it significantly accelerated the rate of SPWs with-
out affecting any of the other characteristics of SPWs or
the ripple oscillation. At concentrations greater than 100
µM the drug significantly slowed down the rate of SPWs
(Fig. 7A). Significant effects on other measures were
observed only at the highest concentration used (400 µM)
which corresponded to the highest clinically employed
concentrations [42,66-69]. Specifically, only at a concen-
tration of 400 µM did phenobarbital significantly reduce
the auto-correlation of SPWs (Fig. 7B), significantly
increase the half-width (Fig. 7C) and significantly reduce
the quantity of ripples (number, duration and power, Fig.
8). At the very high concentration of 1.6 mM abolishment
of the spontaneous activity was observed (n = 3).
Discussion
The present findings demonstrate that thiopental, at clin-
ically relevant concentrations known to impair memory,
produces a significant reduction in the incidence, rhyth-
micity and synchrony of hippocampal SPWs and a con-
comitant reduction in the quantity, but not in theBMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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Effects of thiopental on Ripple oscillation Figure 4
Effects of thiopental on Ripple oscillation. A. Examples of ripple oscillation (filtered traces) from three slices (a-c) illus-
trating the concentration-dependent reversible reduction in number of ripples and duration of ripple episode by thiopental. 
Note that even at 100 µM of the drug, which strongly suppressed the amount of ripples, the oscillation frequency remained 
unchanged. B. Power spectra from three experiments (a-c) showing the reduction of ripple power at 50 and 100 µM but not at 
lower concentrations. C. Plots of collective data of drug effects (percent changes) on the various measures of ripple oscillation. 
Asterisks mark the lowest concentration with statistically significant drug action (see text for details of statistical analysis). 
Note that ripple number and ripple episode duration were more sensitive than ripple power and ripple amplitude. Measures of 
number, duration and amplitude for each of the five drug concentrations (10, 25, 50, 100 and 200 µM) were respectively col-
lected from 10, 12, 17, 10 and 8 slices. The corresponding numbers of slices for ripple power measures were respectively 12, 
14, 22, 15, and 9. D. Recordings of ripples (upper traces) and multiunits (middle traces), revealed after filtering original records, 
showing the thiopental-induced reduction in the rate of multiunits during ripple episodes. Dotted line indicates the threshold 
level set in this experiment for spike detection. Histograms of multiunit rate (bottom panel) triggered by peaks of SPWs (not 
shown) used to measure the mean rate under the different experimental conditions.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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frequency, of SPW-associated ripple oscillation. On the
other hand, clinically relevant concentrations of pheno-
barbital did not significantly affect SPW-R complexes.
Thiopental effects on in vitro SPW-R complexes
Thiopental acts in slowing or disrupting gamma [71-73],
beta [61] and theta oscillations [58,65]. The present study
examined, for the first time, the effects of the drug on both
SPWs and ripple oscillation. Previous in vivo studies have
shown that the barbiturate pentobarbital slows down or
abolishes SPWs at pre-anesthetic or anesthetic doses
respectively [12,74]. The general anesthetic methohexital
displays analogous effects on in vitro SPWs [75], and the
inhaled anesthetic halothane prevents the appearance of
ripples [48]. We observed that thiopental induced concen-
tration-dependent slowing and disorganization of SPW-
Rs, resulting apparently in abolishment of the spontane-
ous activity at high drug concentrations. Thiopental
strongly reduced the rate of SPWs and significantly pro-
longed single SPWs at concentrations producing sedation
(~50–150 µM) [53,54] and anesthesia (>150 µM) [49,53-
55], but see also [50].
SPWs generation depends on excitatory and inhibitory
synaptic transmission mediated by glutamatergic non-
NMDA [28,29,31,62,76] and GABAA receptors [28,29,62]
respectively, and intense activation of inhibitory interneu-
rons has been observed in vivo [15,47,48,77] and in vitro
[78]. SPW-associated ripple oscillation is a high-frequency
(100–200 Hz) field event generated from the interaction
between pyramidal cells and inhibitory interneurons
[8,16,46-48,79], with proposed prominent role of the
interneurons [46-48].
At the cellular level, thiopental enhances GABAA receptor-
mediated phasic inhibitory events [58-60,80-82], charac-
teristically prolonging them [58-60,80,81]. The degree of
drug-induced prolongation of inhibitory postsynaptic
currents or potentials (IPSC/P) has been correlated to the
degree of frequency reduction of those network oscilla-
tions, like theta [58], gamma and beta [60,61,71], whose
period is at the range of IPSC duration. SPWs occurring
every ~0.5 sec, display a period longer than the duration
of fast IPSPs, making thus less likely the involvement of
enhanced GABAA-mediated phasic inhibition in the drug-
induced reduction of the rate of SPWs. However, as sug-
gested by recent data [83], the important implication of
phasic GABAergic transmission in the initiation of SPW-R
events should be taken into account and therefore its role
on the rate of SPWs should not be ruled out. At concentra-
tions ≥50 µM thiopental enhances GABAA receptor-medi-
ated tonic inhibition in hippocampal pyramidal cells
[58,71] and interneurons [56], and directly activates
GABAA receptors [58,82]. Enhancement of tonic inhibi-
tion affects neuronal excitability [56,84-86], and mode-
ling data implicates tonic inhibition in slowing network
oscillations [61,72]. Moreover, slowing of SPWs occurs
under conditions of reduced neuronal excitability [87]. In
the present study, thiopental reduced neuronal excitabil-
ity, as observed by the reduction of unit activity. There-
fore, the enhancement of tonic inhibition and the direct
activation of GABAA receptors appears a likely explanation
for the slowing down of SPWs. Thiopental could affect the
rate of SPW-R activity by disturbing excitatory synaptic
transmission, since slowing or even abolishment of SPWs
has been observed whenever excitatory synaptic transmis-
sion is reduced [29], (Papatheodoropoulos, unpublished
observations). However, we did not observe any signifi-
cant drug effect on the fEPSPs.
Thiopental prolongs IPSPs in pyramidal neurons and in
the present study the drug significantly prolonged SPWs.
During in vitro SPWs both depolarizing and hyperpolar-
izing components are observed in principal neurons
[31,45,62,63], although in CA3 pyramidal cells some
authors have observed only depolarizing potentials [75].
In our model the most prominent intracellular correlate
of SPWs in CA1 pyramidal neurons is a GABAA receptor-
mediated hyperpolarization [28]. Thus, the prolongation
of SPWs induced by thiopental might involve to some
Thiopental did not affect fEPSPs Figure 5
Thiopental did not affect fEPSPs. A-B. Evoked fEPSPs 
from CA1 st. radiatum (upper traces, averages of ten 
sweeps) and continuous records of SPW-Rs from CA1 st. 
pyramidale (lower traces) obtained in normal medium (left 
panels) and in medium containing 50 or 100 µM of thiopental 
(right panels). fEPSPs and spontaneous activity were simulta-
neously recorded from two neighboring slices in "A" and 
from the same slice in "B". Note that the drug did not affect 
fEPSPs despite its suppressive effect on spontaneous activity. 
C-D. Grouped data of fEPSP slope for the two concentra-
tions of thiopental. The drug did not significantly change the 
slope of fEPSP at any concentration.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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Thiopental action on SPW-Rs does not involve NMDA-mediated synaptic transmission Figure 6
Thiopental action on SPW-Rs does not involve NMDA-mediated synaptic transmission. A. Representative histo-
gram of instantaneous period of SPW-R activity recorded from the CA1 st. pyramidale. Thiopental (50 µM, red bar), applied in 
the presence of NMDA receptor antagonist CPP (10 µM, blue bar) produced reversible reduction in the rate of SPWs, a simi-
lar effect to that observed when the anesthetic was applied alone (compare with Fig. 3A). Inserts show examples of SPWs 
(traces on the top, low-pass filtered) and ripples (traces on the bottom, band-pass filtered) selected from times before and dur-
ing thiopental application (arrows indicating the panel on the left and right respectively). Note that under thiopental SPWs are 
prolonged and ripple episode was shortened, containing decreased number of ripple waves. Calibration bars in the inserts: 50 
µV, 25 ms for SPW; 25 µV, 50 ms for ripples. B. Histogram of instantaneous period of SPW-R activity recorded from the CA1 
st. pyramidale of a slice which received 100 µM of thiopental (red bar) in the presence of CPP (blue bar). Inserts show the 
power spectra, at the ripple range, generated from epochs of 2 min taken from the different conditions (i.e. in CPP, in thiopen-
tal and after washing-out thiopental) as indicated by arrows. C-D. Collective data of the effects of thiopental on SPWs' (C) and 
Ripples' (D) measures in the presence of CPP. Measures of SPWs and Ripples were obtained from 9 and 7 slices respectively, 
at the concentration of 50 µM and from 8 and 5 slices respectively at the concentration of 100 µM. Asterisks indicate statisti-
cally significant drug effects (paired t-test, at P < 0.05). Error bars not shown were smaller than the size of the symbol.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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Effects of phenobarbital on SPWs Figure 7
Effects of phenobarbital on SPWs. A. SPW-R complexes recorded from a slice bathed in normal medium and under con-
sequently increasing concentrations of phenobarbital (a) showing that the rate of spontaneous activity was increased at 50 and 
100 µM and reduced at 200 and 400 µM (asterisk denotes the lowest drug concentration with statistical significance effect, 
paired t-test, P < 0.001 paired t t-test, P < 0.05). In the plot of instantaneous period (b) note that even at the highest concen-
tration (400 µM) phenobarbital did not abolish spontaneous activity. Measures for constructing the plot of collective data (c) 
were obtained from 3, 6, 10, 12 and 18 slices respectively for the five drug concentrations. B. Example of auto-correlation anal-
ysis for SPWs recorded in one slice before and during application of 100 µM of phenobarbital (diagram on the left). The collec-
tive data plot (diagram on the right) illustrates that only at 400 µM did the drug significantly reduce rhythmicity of SPWs 
(asterisk, P < 0.05). Data were obtained from 6, 10, 10 and 12 slices respectively for the four drug concentrations. C. Averages 
of filtered SPWs recorded from an epoch lasting two minutes (a) obtained from a slice bathed in normal medium (trace with 
the smallest amplitude) and increasing concentrations of phenobarbital (50, 200 and 400 µM, traces with consecutively increas-
ing amplitude). Note the concomitant increase in the falling phase and the amplitude of the potentials. The drug significantly 
increased half-width of SPWs at the highest concentration of 400 µM (b). However, the drug did not significantly change the 
amplitude of SPWs at any concentration (c). Data in collective plots were obtained from 6, 10, 12 and 18 slices respectively for 
the four drug concentrations in half-width and from 3, 6, 10, 12 and 18 slices for the five concentrations in amplitude. D. Phe-
nobarbital significantly decreased synchronization only at 400 µM, as illustrated in the example (on the left) and collective dia-
gram (on the right, paired t-test, P < 0.05). The concentration of 25 µM is missing from the plots of auto-correlation, half-width 
and cross-correlation because measures of these variables were obtained from only one experiment.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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extends prolongation of GABAA receptor-mediated IPSPs
in pyramidal cells. In this line, the absence of thiopental
effect on the amplitude of SPWs is consistent with the
observation that the drug, similarly to other barbiturates,
does not affect the amplitude of GABAA receptor-mediated
synaptic events [58-60,80], but see also [82].
In similarity to the previously observed disruptive effects
of thiopental on rhythmicity and synchronization of in
vitro theta, gamma and beta oscillations [58,61,72], at
clinically relevant concentrations (≥25  µM), thiopental
strongly suppressed rhythmicity and spatial synchroniza-
tion of SPWs. The high degree of synchronization is actu-
ally one of the major common characteristics between in
vivo [12,88] and in vitro SPWs [27-30], whereas rhyth-
micity characterizes mostly the in vitro [31] (Fig. 1E)
rather than the in vivo SPWs [12]. Disruption of syn-
chrony of network oscillations along the CA1 region
occurs as a result of the combination of the prolongation
of GABAA  receptor-mediated synaptic events with
Effects of phenobarbital on Ripple oscillation Figure 8
Effects of phenobarbital on Ripple oscillation. A. Examples of ripple oscillation obtained from one recording session 
showing that phenobarbital reversibly shortened ripple episode only at 400 µM (asterisks, paired t-tests, P < 0.05). B. Power 
spectra obtained from different times of a single experiment illustrating the reduction in ripple power only at high drug concen-
trations (200 and 400 µM). C. Diagrams of collective data for the different measures of the ripple oscillation. Note that the 
reducing effect of phenobarbital on number, duration and ripple power was statistically significant (asterisks, P < 0.05) only at 
the highest concentration of 400 µM. Measures of the above variables (except power) at the five drug concentrations were 
obtained from 2, 3, 7, 5 and 9 slices. Values of power were obtained from 4, 7, 12, 9 and 12 slices.BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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enhanced tonic inhibition [72]. Thus, the thiopental-
induced enhancement of GABAA receptor-mediated pha-
sic and tonic conductances might also underlie the drug
effects on synchrony and rhythmicity of SPWs.
Ripple oscillation was affected by thiopental at concentra-
tions ≥25 µM. During ripple oscillation certain types of
interneurons and a small fraction of pyramidal cells
increase their activity following a temporally very precise
firing pattern [46-48,77]. Therefore, excitability changes
in these neurons would predict alterations in ripple oscil-
lation characteristics. Among interneurons, bistratified
and basket cells selectively fire during the whole ripple
episode [77]. Thus, presumably the activity of these
interneurons determines the duration of ripple episodes.
We hypothesized that thiopental-induced reduction of
excitability in bistratified and basket cells is critically
involved in the drug effects on ripple oscillation. Interest-
ingly, recent evidence [89] suggests that these particular
types of interneurons (i.e. bistratified and basket cells) are
at a relatively higher state of tonic inhibition compared to
other types of inteneurons. Hippocampal interneurons
but not pyramidal cells possess a baseline GABAA recep-
tor-mediated tonic inhibition [85]. It might then be the
case that interneurons, compared with pyramidal cells,
display a greater susceptibility to thiopental-induced
reduction in excitability through enhancement of tonic
inhibition. This is consistent with the lower drug concen-
tration needed to reduce ripple quantity (duration and
number) compared with SPW's rate and duration. Fur-
thermore, it supports the important role of interneurons
in normal ripple generation, although oscillations at the
ripple's frequency range can be observed under experi-
mental conditions of disinhibition [83,90,91].
Comparison of effects between thiopental and 
phenobarbital
The distinct effects of the two drugs on SPW-R activity,
achieved at clinically relevant concentrations, resemble
their differing sedative and amnesic effects. The effects of
thiopental on SPW-Rs are presumably mediated via
GABAA receptor mechanisms, since they are achieved at
concentrations falling in the range of drug interaction
with the GABAA receptor. On the other hand, the com-
monly employed anticonvulsant concentrations of phe-
nobarbital (<300 µM) [42,66-69] are lower than those for
effective drug interaction with the GABAA receptor (>300
µM) [42,68,92-95], but see also [96]. It appears therefore
that the much lower effects of phenobarbital on SPW-R
activity in comparison to those of thipoental's, might
reflect its actual lower impact as an enhancer of GABAA
receptor function.
Implications
SPW-R activity has been implicated in the processes of
information transfer between hippocampus and neocor-
tex subserving memory consolidation [17,19,22,88,97].
Thiopental-induced impairment of explicit memory
occurs at drug serum concentrations less than 30 µM
[1,35,98]. Interestingly, the lowest concentration of the
drug interfering with ripples and synchrony and rhyth-
micity of SPWs (25 µM) actually equates to the Cp50
value for 50% explicit memory impairment [1]. Further-
more, the only concentration of phenobarbital (200 µM)
which significantly reduced the quantity of ripples was
comparable to that producing explicit memory loss [42].
The present results show that thiopental affects the quan-
titative parameters of the ripple oscillation (i.e. the
number, duration and power) but not the frequency of
the oscillation. Consistently, it has been recently shown
that cannabinoids, which induce memory impairment,
produce reduction of the power but not of the frequency
of the ripple oscillation [99]. Considering the proposed
role of SPW-Rs in memory consolidation [17,23,24], as
well as the in vitro induction of SPW-Rs in association
with long-term synaptic plasticity [31], the interfering
effects of thiopental on SPW-R activity might disrupt the
hippocampal network-dependent transformation of
short-term into long-term memory storage. This is in line
with previous data showing that the processes involved in
the formation of long-term explicit memories are sensitive
to anesthetic agents [36,51,100].
SPW-R complexes can be triggered by neocortical input
[8,101,102]. It could therefore be argued that thiopental
exerts its amnesic actions by acting on the neocortical cir-
cuit, which only secondarily influences hippocampal
function. On the other hand, the in vitro generation of
SPW-Rs in hippocampal slices [27,30,31,87], in the iso-
lated whole hippocampus [29], as well as their in vivo
occurrence in the grafted hippocampus [29,43] show that
they are an intrinsic hippocampal activity. Furthermore,
the emergence of this activity is presumably based on
strengthened synapses in the same local hippocampal cir-
cuit [29,31,103]. Consequently, the present evidence sug-
gests that thiopental mediates its amnesic effects by
directly acting on the local hippocampal circuit, and thus
interfering with the hippocampo-neocortical communica-
tion, as observed also in the case of theta oscillation
[29,54]. Finally, the present results are consistent with the
emergent consensus on the weakening role that GABAer-
gic transmission exerts on the memory processes [104].
Conclusion
Thiopental, presumably by disturbing the well regulated
balance between excitation and inhibition, interferes with
hippocampal SPW-R activity. The action of thiopental was
observed at relatively low drug concentrations reported toBMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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induce mild sedation and explicit memory impairment.
The drug-induced reduction in quantity but not frequency
of the ripple oscillation is suggestive of the importance of
the former parameter as a basic functional feature of the
SPW-associated high-frequency oscillation. We hypothe-
size that the thiopental-induced effects on SPW-R activity
are implicated in the drug-induced impairment of hippoc-
ampus-involving memory processes.
Methods
Slice preparation
Hippocampal slices were prepared from male Wistar rats,
4–10 weeks old, housed in a room with a controlled tem-
perature (22–24° C), 12/12 hrs light-dark cycle. All meas-
ures were taken to minimize animal suffering and to
reduce the number of the animals used, according to the
European Communities Council Directive Guidelines
(86/609/EEC) for the care and use of Laboratory animals.
Animals were deeply anaesthetized with diethyl-ether and
decapitated. The brain was removed and placed in chilled
(2–4°C) artificial cerebrospinal fluid (ACSF) and the two
hippocampi were excised free. Using a McIlwain tissue
chopper, transverse slices (500–550 µm thick) were pre-
pared from the ventral hippocampus, as previously
described [87]. The slices were immediately transferred on
the two independent channels of an interface type record-
ing chamber and maintained at a constant temperature of
32 ± 0.2°C. In some experiments the temperature was
changed in order to observe its effects on the spontaneous
activity (see Results). The slices were continuously humid-
ified with 95% O2 and 5% CO2 mixed gas and perfused at
a rate of 0.8–1.0 ml/min with standard ACSF containing
(in mM): 124 NaCl; 4 KCl; 2 MgSO4; 2 CaCl2; 1.25
NaH2PO4; 26 NaHCO3; 10 glucose; at pH 7.4, equili-
brated with 95% O2 and 5% CO2 gas mixture. Drugs
included thiopental (Pentothal, Abbott Laboratoires,
S.p.A. Italy) phenobarbital (Sigma, USA) and the NMDA
receptor antagonist 3-((R)-2-Carboxypiperazin-4-yl)-pro-
pyl-1-phosphonic acid (CPP, Tocris, UK). All drugs were
prepared as stock solutions and then were dissolved in
ACSF and bath applied. CPP was applied for at least fif-
teen minutes before the application of thiopental. Thio-
pental and phenobarbital were applied for thirty minutes.
In some experiments thiopental was applied for longer
periods, as indicated in figures.
Electrophysiological Recordings
Field potentials were recorded from CA1 or CA3 stratum
pyramidale or st. radiatum using carbon fibre electrodes,
of a diameter either 7 µm (homemade) or 10 µm (World
Precision Instruments Inc., USA). A bipolar platinum/
iridium electrode (25 µm) located in stratum radiatum
was used for electrical stimulation of the Schaffer collater-
als (pulses: 0.3–0.9 mA/0.1 ms). Spontaneous field
potentials were gradually organized in the ventral hippoc-
ampal slices during the first 2–3 h of their maintenance in
the recording chamber, under standard conditions. Spon-
taneous activity was fully organized in terms of amplitude
and frequency after about three hours from slice place-
ment on the chamber (Fig. 1A). Stabilized activity was
recorded constantly for at least three hours thereafter
without interruption or considerable decline in amplitude
and frequency of occurrence. Activity in many slices was
stable for more than seven hours. The consistency over
time (i.e. the stability of phenomenological characteris-
tics, like frequency and amplitude) allows the detailed
examination of pharmacological effects over a wide time
scale. In order to determine the degree of synchrony of
sharp waves (SPWs) across CA1 st. pyramidale two simul-
taneous field recordings were made along the pyramidal
layer at a fixed distance of 1 mm.
Data processing, Measurements and Analysis
Signals were band-pass filtered at 0.5 Hz – 2 kHz using a
Neurolog amplifier system (Digitimer Limited, UK), and
a Grass AC/DC amplifier when double simultaneous
recordings were performed. Data were digitized at 4 kHz
and stored in a computer disk using the CED 1401-plus
interface and analyzed off-line using the Spike2 and Sig-
nal software (Cambridge Electronic Design, Cambridge,
UK).
Spontaneous activity in stratum pyramidale consisted of a
positive slow wave consistently ridden by a burst-like
high-frequency activity. The latter was mainly manifested
during slow wave's rising and peaking phase (Fig. 1C1).
Measures of the spontaneous activity were performed on
the slow and high frequency components, which were dis-
closed after filtering original recordings at different fre-
quency windows (Fig. 1C-2,C3 and 1C4). Specifically,
SPWs were detected after low-pass filtering the original
signal at 35 Hz and setting a threshold at a level in which
all putative events, verified by visual inspection, were
marked. In some experiments, in which the amplitude of
SPWs was greatly reduced during the pharmacological
procedure, adjustment of the threshold was required in
order to make the detection of all events in the record reli-
able. SPWs were quantified by the following measures: a)
period, determined as the time interval between the peaks
of successive waves; b) amplitude, determined as the volt-
age difference between the positive peak and the baseline;
c) duration, determined as the time elapsed between the
two points of intersection of the field positive waveform
with the baseline; d) half-maximal width, determined as
the time elapsed between the two points of intersection of
the field waveform with the horizontal line passing
through the half-maximal amplitude of the wave. Meas-
ures of duration and half-maximal width were performed
on the average sweep calculated from at least thirty single
events; e) auto-correlation, used as an index of the rhyth-BMC Neuroscience 2007, 8:60 http://www.biomedcentral.com/1471-2202/8/60
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micity of SPWs, was estimated by the amplitude of the
first side-peak of the auto-correlogram [105]; f) cross-cor-
relation, measured by the peak amplitude of the corre-
sponding cross-correlogram calculated using
simultaneous recordings from two slice locations with a
distance between them of 1 mm. Cross-correlation was
used as an index of the synchronization of SPWs along the
pyramidal layer. The measures of period, amplitude and
duration of SPW were made from two minute long epochs
of low-pass filtered record. Auto-correlation and cross-
correlation were obtained from a recording epoch lasting
ten to twenty seconds. Ripples were detected after band-
pass filtering original records at 80–300 Hz (1C-3) and
setting a threshold at four times the standard deviation of
event-free baseline noise. Furthermore, events were cate-
gorized as ripples only when episodes of at least three con-
secutive negative deflections were observed with delays
between them of at least 2 ms and no more than 11 ms,
i.e. they should have a frequency falling within the range
of 90–500 Hz [62]. Threshold was further verified by vis-
ual inspection. Ripples were therefore quantified by their:
a) number of ripples inside a ripple event, estimated by
the number of negative deflections inside an event; b)
duration of the ripple event; c) intra-ripple frequency,
determined as the reciprocal of the value of the mean
inter-ripple interval; d) amplitude, determined as the volt-
age difference between the positive and negative maxi-
mum in each ripple event. Measures of ripple
characteristics from each slice or condition were made
from thirty consecutive ripple events. Ripple power and
frequency were additionally verified from power spectra
applied to five minute long raw record. Multiunit activity
was revealed by band-pass filtering data at 500–1000 Hz,
and the negative spikes were detected setting the thresh-
old level four times the standard deviation of event-free
baseline noise.
Examination of drug effects on SPW-R activity was per-
formed only on those slices displaying stable activity for
at least fifteen minutes. For that, the power of ripples and
the auto-correlation in SPWs were on-line analyzed and
monitored in a continuous manner. Whenever recordings
were made from two locations in the same slice, cross-cor-
relation analysis was also continuously monitored.
Values through the text are expressed as mean ± S.E.M.,
and "n" indicates the number of slices included in the
analysis. For statistical comparisons of the effects of thio-
pental and phenobarbital on SPW-Rs, measures were
taken before drug application and thirty minutes after
drug application. We used SPSS 14 for statistical analysis
(paired and independent t-tests), Origin 7 to make figures
and Reference Manager 10 to construct the list of refer-
ences.
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